A lesson in how not to run for public office — in Canada or anywhere else
In his latest blog, Paul Thacker, an investigator for the Project on Government Oversight (POGO) and former aide to Senator Charles Grassley, struggles to understand how Dr. Stan Kutcher, a...
View ArticleUPenn President is urged to resign as chair of Obama’s bioethics commission...
The Project on Government Oversight (POGO) has called on President Obama to remove Amy Gutmann, University of Pennsylvania’s president, as chair of his presidential commission for the study of...
View ArticleWhat’s behind the growing rate of scientific retractions?
The retraction of studies in medical and scientific journals has surged in the last decade, according to separate analyses done by the Wall Street Journal and Retraction Watch. In its page-one article...
View ArticleAllegations of fraud and extensive ghostwriting form core of upcoming Texas...
On November 28, the Texas Attorney General is expected to begin a landmark trial against Johnson & Johnson on charges that the pharmaceutical giant “subverted scientific integrity” by paying off...
View ArticleInternational group seeks Brown University’s help in retracting controversial...
The international research organization Healthy Skepticism has called on Brown University to help convince a psychiatric journal to retract the controversial Paxil trial that I wrote about in Side...
View ArticleDeceptive drug research practices explain why over-medicating of children...
A new report from the U.S. Government Accountability office confirms something that Rose Firestein, the eponymous prosecutor in the title of Side Effects: A Prosecutor, a Whistleblower and Bestselling...
View ArticleEnforcing anti-kickback laws: a powerful deterrent against ghost-writing in...
The Obama administration recently made it clear that it will require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment under the...
View ArticleWhen it comes to scientific misconduct, should there be a statute of...
I was hesitant to weigh in at first when I learned that Brown University’s School of Medicine had decided not to pressure a psychiatric journal to retract the seriously flawed Paxil study that I wrote...
View ArticleCalls for action against authors of controversial Paxil study are getting louder
In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study...
View ArticleMartin Keller, principal investigator of Paxil study 329, retires from Brown...
I just learned that Dr. Martin Keller, principal investigator of the controversial Paxil study 329, has retired from his position as a professor of psychiatry at Brown University — see here. As...
View Article
More Pages to Explore .....